Stevanato Group Spa
STVN
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.53B
Close$
$3.69
82.7% downside
Current Fair Value
82.7% downsideOvervalued by 82.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.53 Billion |
|---|---|
| Enterprise Value | $5.96 Billion |
| Dividend Yield | $0.06 (0.31%) |
| Earnings per Share | $0.49 |
| Beta | 0.78 |
| Outstanding Shares | 273,003,694 |
Return
| Return on Equity | 9.21% |
|---|---|
| Return on Assets | 5.46% |
| Return on Invested Capital | 9.88% |
Valuation & Multiples
| P/E Ratio | 34.38 |
|---|---|
| PEG | 603.01 |
| Price to Sales | 5.31 |
| Price to Book Ratio | 4.25 |
| Enterprise Value to Revenue | 4.97 |
| Enterprise Value to EBIT | 29.82 |
| Enterprise Value to Net Income | 42 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.14
Average shareholder expectationRevenue Estimate
$340.58 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.17
Average shareholder expectationRevenue Estimate
$371.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.55%▼ 8.77% |
|---|---|
| Total Invested | $372.53M▼ 39.20% |
| Investors Holding | 50▼ 86.00% |
ESG Score
No data
About Stevanato Group Spa
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end por...